These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Bacillus Calmette-Guérin and superficial bladder cancer. Clinical experience and mechanism of action. Catalona WJ, Ratliff TL. Surg Annu; 1990; 22():363-78. PubMed ID: 2408170 [No Abstract] [Full Text] [Related]
46. Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review. Caramori G, Artioli D, Ferrara G, Cazzuffi R, Pasquini C, Libanore M, Guardigni V, Guzzinati I, Contoli M, Rossi R, Rinaldi R, Contini C, Papi A. Monaldi Arch Chest Dis; 2013 Mar; 79(1):44-8. PubMed ID: 23741946 [Abstract] [Full Text] [Related]
47. [A Case Diagnosed as Iatrogenic Vesical Tuberculosis 4 Years after Intravesical Immunotherapy Using Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Carcinoma]. Kudo T, Iwasa N, Maeda S, Mitarai S. Kansenshogaku Zasshi; 2016 Nov; 90(6):809-13. PubMed ID: 30277373 [Abstract] [Full Text] [Related]
48. Miliary pulmonary tuberculosis following intravesical BCG therapy: case report and literature review. Colmenero JD, Sanjuan-Jimenez R, Ramos B, Morata P. Diagn Microbiol Infect Dis; 2012 Sep; 74(1):70-2. PubMed ID: 22749242 [Abstract] [Full Text] [Related]
50. Molecular confirmation of bacillus Calmette-Guérin as the cause of pulmonary infection following urinary tract instillation. Kristjansson M, Green P, Manning HL, Slutsky AM, Brecher SM, von Reyn CF, Arbeit RD, Maslow JN. Clin Infect Dis; 1993 Aug; 17(2):228-30. PubMed ID: 8104511 [Abstract] [Full Text] [Related]
52. Abdominal aortic aneurysmal and endovascular device infection with iliopsoas abscess caused by Mycobacterium bovis as a complication of intravesical bacillus Calmette-Guérin therapy. Mizoguchi H, Iida O, Dohi T, Tomoda K, Kimura H, Inoue K, Iwata T, Tei K, Miura T. Ann Vasc Surg; 2013 Nov; 27(8):1186.e1-5. PubMed ID: 23972639 [Abstract] [Full Text] [Related]
53. Intravesical Bacillus Calmette Guerin therapy in patients with superficial bladder tumor. Steg A, Belas M, Leleu C, Boccon-Gibod L. Prog Clin Biol Res; 1989 Nov; 303():375-81. PubMed ID: 2780654 [No Abstract] [Full Text] [Related]
54. [Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report]. Shiba M, Fujii T, Takatera H. Hinyokika Kiyo; 2003 Oct; 49(10):599-601. PubMed ID: 14655604 [Abstract] [Full Text] [Related]
55. Mycobacterium bovis discitis as a complication of intravesical Bacillus Calmette-Guérin therapy. Colebatch AN, Mounce KE. J Clin Rheumatol; 2010 Mar; 16(2):74-5. PubMed ID: 20130477 [Abstract] [Full Text] [Related]
56. Granulomatous hepatitis as a complication of intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma. Arzt MR, Forouhar F. Ann Clin Lab Sci; 1995 Mar; 25(5):409-13. PubMed ID: 7486816 [Abstract] [Full Text] [Related]
57. [Miliary induced by intravesical BCG immunotherapy for carcinoma of the bladder: CT Findings]. Mignon F, Chevrière A, Mesurolle B, El Hajam M, Morel H, Lacombe P. J Radiol; 2002 Mar; 83(3):368-71. PubMed ID: 11979232 [Abstract] [Full Text] [Related]
58. Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma. Larsen BT, Smith ML, Grys TE, Vikram HR, Colby TV. Int J Surg Pathol; 2015 May; 23(3):189-95. PubMed ID: 25614462 [Abstract] [Full Text] [Related]